This page addresses follow-up questions and additional information pertinent to our webinar
Breaking News: 2026 ICD-10-CM Coding Update.
** The coding information and guidance are valid at the time of publishing. Learners are encouraged to research
subsequent official guidance in the areas associated with the topic as they can change rapidly.
Q: Does the new ICD-10-CM code for type 2 diabetes in remission change Coding Clinic’s guidance from 1st Quarter 2020 when a complication is present?
A: No. The new code does not change the guidance published in Coding Clinic, First Quarter 2020, page 12. That guidance clarifies that even when a patient’s blood sugars are normal and they are no longer considered diabetic, any existing complication of diabetes (for example, diabetic chronic kidney disease) must still be coded as a diabetic complication.
Q: When should code E11.A (Type 2 diabetes mellitus in remission) be assigned?
A: Code E11.A should only be used when there are no diabetic complications. If a complication is present, the appropriate diabetes code with complication should be assigned instead.
Q: What is the difference between nephritic and nephrotic syndrome?
A: Nephrotic syndrome is primarily a protein problem. Damage to the glomeruli increases permeability, causing large amounts of protein to leak into the urine. This leads to edema and may also result in lipiduria (fat in the urine). Nephritic syndrome is primarily a blood problem. Inflammation of the glomeruli allows red blood cells to pass into the urine, leading to hematuria and often hypertension. In short, nephrotic syndrome is characterized by massive protein loss, while nephritic syndrome is defined by blood and inflammation-related findings.
Q: What is diethylstilbestrol (DES)?
A: Diethylstilbestrol (DES) is a synthetic form of estrogen that was prescribed to pregnant women between 1940 and 1971 to help prevent miscarriage, premature labor, and other pregnancy-related complications. Subsequent research revealed that DES is an endocrine-disrupting chemical. Exposure to DES has been associated with an increased risk of certain cancers, birth defects, and other developmental abnormalities in both those who took the medication and their children.
Looking for additional information on this topic?
Meet the Presenter: Kristi Pollard, RHIT, CCS, CPC, CIRCC
Kristi is the Director of Coding Quality & Education with more than 25 years of industry experience; she is responsible for the development of web-based, instructor-led, and webinar training materials; conducting training in ICD-10-CM/PCS and CPT; and performing DRG and APC audits. Kristi has an extensive background in coding education and consulting and is a national speaker and published writer on topics related to ICD-10 and CPT coding and code-based reimbursement. She has designed and developed training programs for inpatient and outpatient hospital-based coding, with a focus on vascular interventional radiology, interventional cardiology, orthopedics, and obstetrics.
very informative
Thank you Kristi P. for a very clear and explicit, interesting and informative webinar
Thank you for this helpful information.
Thank you. This was very helpful.
Very informative
Thank you for this excellent presentation. Very informative
Thank you excellent presentation. Right pace and very professional presenter, Kristi kudos!